Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DNC000364

Drug Information
NameBW A4C
IndicationNot AvailableExperimental    

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESCC(=O)N(CC=CC1=CC(=CC=C1)OC2=CC=CC=C2)O    
Isomeric SMILESCC(=O)N(C/C=C/C1=CC(=CC=C1)OC2=CC=CC=C2)O
CAS NumberCAS 106328-57-8
PubChem Compound IDCID 6438354.
PubChem Substance IDSID 700722.
TargetArachidonate 5-lipoxygenaseInhibitor[1][2][3][2]
Ref 1Reactive oxygen species and lipoxygenases regulate the oncogenicity of NPM-ALK-positive anaplastic large cell lymphomas. Oncogene. 2009 Jul 23;28(29):2690-6. Epub 2009 Jun 8. To Reference
Ref 2Tumour necrosis factor production in a rat airpouch model of inflammation: role of eicosanoids. Agents Actions. 1991 Mar;32(3-4):289-94. To Reference
Ref 3Hydroxamic acids and hydroxyureas as novel, selective 5-lipoxygenase inhibitors for possible use in asthma. Agents Actions Suppl. 1991;34:189-99. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543